KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Capital Leases (2016 - 2018)

Charles River Laboratories International has reported Capital Leases over the past 9 years, most recently at $29.2 million for Q4 2018.

  • For Q4 2018, Capital Leases fell 3.5% year-over-year to $29.2 million; the TTM value through Dec 2018 reached $29.2 million, down 3.5%, while the annual FY2018 figure was $29.2 million, 3.5% down from the prior year.
  • Capital Leases for Q4 2018 was $29.2 million at Charles River Laboratories International, down from $30.8 million in the prior quarter.
  • Over five years, Capital Leases peaked at $35.8 million in Q2 2015 and troughed at $717000.0 in Q1 2014.
  • A 5-year average of $26.2 million and a median of $30.3 million in 2017 define the central range for Capital Leases.
  • Biggest five-year swings in Capital Leases: skyrocketed 3428.59% in 2015 and later decreased 19.27% in 2016.
  • Year by year, Capital Leases stood at $1.0 million in 2014, then surged by 3260.0% to $33.6 million in 2015, then dropped by 11.01% to $29.9 million in 2016, then grew by 1.34% to $30.3 million in 2017, then dropped by 3.5% to $29.2 million in 2018.
  • Business Quant data shows Capital Leases for CRL at $29.2 million in Q4 2018, $30.8 million in Q3 2018, and $30.6 million in Q2 2018.